| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | ethanol binding | 6.61e-10 | 6 | 53 | 4 | GO:0035276 | |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 4.52e-07 | 24 | 53 | 4 | GO:0004745 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 6.33e-07 | 26 | 53 | 4 | GO:0004022 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 1.15e-06 | 30 | 53 | 4 | GO:0018455 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 9.65e-06 | 16 | 53 | 3 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 2.27e-05 | 21 | 53 | 3 | GO:0030228 | |
| GeneOntologyMolecularFunction | NAD binding | 4.20e-05 | 73 | 53 | 4 | GO:0051287 | |
| GeneOntologyMolecularFunction | neuroligin family protein binding | 6.88e-05 | 5 | 53 | 2 | GO:0097109 | |
| GeneOntologyMolecularFunction | alcohol binding | 1.55e-04 | 102 | 53 | 4 | GO:0043178 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | 3.59e-04 | 127 | 53 | 4 | GO:0016616 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | 4.92e-04 | 138 | 53 | 4 | GO:0016614 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 1.50e-03 | 85 | 53 | 3 | GO:0038024 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 1.55e-03 | 188 | 53 | 4 | GO:0005201 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 2.33e-03 | 27 | 53 | 2 | GO:0005044 | |
| GeneOntologyBiologicalProcess | acetaldehyde biosynthetic process | 1.60e-08 | 3 | 53 | 3 | GO:0046186 | |
| GeneOntologyBiologicalProcess | ethanol catabolic process | 9.02e-08 | 17 | 53 | 4 | GO:0006068 | |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 1.16e-07 | 18 | 53 | 4 | GO:0006067 | |
| GeneOntologyBiologicalProcess | acetaldehyde metabolic process | 1.60e-07 | 5 | 53 | 3 | GO:0006117 | |
| GeneOntologyBiologicalProcess | primary alcohol catabolic process | 3.32e-07 | 23 | 53 | 4 | GO:0034310 | |
| GeneOntologyBiologicalProcess | retinoic acid metabolic process | 3.31e-06 | 40 | 53 | 4 | GO:0042573 | |
| GeneOntologyBiologicalProcess | alcohol catabolic process | 6.38e-06 | 47 | 53 | 4 | GO:0046164 | |
| GeneOntologyBiologicalProcess | retinol metabolic process | 1.04e-05 | 53 | 53 | 4 | GO:0042572 | |
| GeneOntologyBiologicalProcess | behavioral response to ethanol | 1.06e-05 | 17 | 53 | 3 | GO:0048149 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 3.71e-05 | 73 | 53 | 4 | GO:1901616 | |
| GeneOntologyBiologicalProcess | aldehyde biosynthetic process | 6.84e-05 | 31 | 53 | 3 | GO:0046184 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 8.07e-05 | 89 | 53 | 4 | GO:0001523 | |
| GeneOntologyBiologicalProcess | olefinic compound metabolic process | 9.79e-05 | 180 | 53 | 5 | GO:0120254 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 9.98e-05 | 94 | 53 | 4 | GO:0016101 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 1.53e-04 | 105 | 53 | 4 | GO:0006721 | |
| GeneOntologyBiologicalProcess | primary alcohol metabolic process | 1.59e-04 | 106 | 53 | 4 | GO:0034308 | |
| GeneOntologyBiologicalProcess | adult behavior | 1.72e-04 | 203 | 53 | 5 | GO:0030534 | |
| GeneOntologyBiologicalProcess | response to testosterone | 3.43e-04 | 53 | 53 | 3 | GO:0033574 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 5.12e-04 | 144 | 53 | 4 | GO:0006720 | |
| GeneOntologyBiologicalProcess | blood vessel development | 5.45e-04 | 929 | 53 | 9 | GO:0001568 | |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | 6.20e-04 | 410 | 53 | 6 | GO:0031589 | |
| GeneOntologyBiologicalProcess | vasculature development | 7.38e-04 | 969 | 53 | 9 | GO:0001944 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 7.60e-04 | 16 | 53 | 2 | GO:0007158 | |
| GeneOntologyBiologicalProcess | response to ethanol | 7.78e-04 | 161 | 53 | 4 | GO:0045471 | |
| GeneOntologyBiologicalProcess | hormone metabolic process | 8.24e-04 | 286 | 53 | 5 | GO:0042445 | |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | 1.07e-03 | 817 | 53 | 8 | GO:0048514 | |
| GeneOntologyCellularComponent | extracellular matrix | THSD4 SNED1 NTN4 LAMB4 ADAMTSL1 FBLN2 ADAMTS9 LRRTM4 LAMA1 TECTA | 5.95e-06 | 656 | 54 | 10 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | THSD4 SNED1 NTN4 LAMB4 ADAMTSL1 FBLN2 ADAMTS9 LRRTM4 LAMA1 TECTA | 6.11e-06 | 658 | 54 | 10 | GO:0030312 |
| GeneOntologyCellularComponent | laminin complex | 2.91e-04 | 10 | 54 | 2 | GO:0043256 | |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | 4.09e-04 | 530 | 54 | 7 | GO:0062023 | |
| MousePheno | abnormal ethanol metabolism | 6.93e-10 | 6 | 38 | 4 | MP:0005443 | |
| MousePheno | abnormal retinol metabolism | 1.61e-09 | 7 | 38 | 4 | MP:0005444 | |
| MousePheno | abnormal vitamin A metabolism | 6.20e-08 | 15 | 38 | 4 | MP:0011233 | |
| MousePheno | abnormal vitamin metabolism | 6.20e-08 | 15 | 38 | 4 | MP:0013244 | |
| MousePheno | abnormal vitamin or vitamin cofactor metabolism | 6.20e-08 | 15 | 38 | 4 | MP:0013274 | |
| MousePheno | enhanced behavioral response to alcohol | 1.01e-05 | 16 | 38 | 3 | MP:0009751 | |
| MousePheno | enhanced behavioral response to xenobiotic | 3.54e-05 | 69 | 38 | 4 | MP:0009746 | |
| MousePheno | abnormal behavioral response to alcohol | 3.61e-05 | 24 | 38 | 3 | MP:0020157 | |
| MousePheno | enhanced behavioral response to addictive substance | 2.27e-04 | 44 | 38 | 3 | MP:0009749 | |
| MousePheno | increased susceptibility to induced morbidity/mortality | 3.11e-04 | 346 | 38 | 6 | MP:0009763 | |
| MousePheno | abnormal descending aorta morphology | 3.90e-04 | 11 | 38 | 2 | MP:0009869 | |
| Domain | EGF-like_CS | SNED1 NTN4 LAMB4 FBLN2 STAB2 NRXN3 NRXN2 LAMA1 WIF1 ADGRE1 MEGF11 EPHA1 CRB1 | 2.94e-13 | 261 | 53 | 13 | IPR013032 |
| Domain | EGF_1 | SNED1 NTN4 LAMB4 FBLN2 STAB2 NRXN3 NRXN2 LAMA1 WIF1 ADGRE1 MEGF11 CRB1 | 5.26e-12 | 255 | 53 | 12 | PS00022 |
| Domain | EGF_2 | SNED1 LAMB4 FBLN2 STAB2 NRXN3 NRXN2 LAMA1 WIF1 ADGRE1 MEGF11 EPHA1 CRB1 | 8.26e-12 | 265 | 53 | 12 | PS01186 |
| Domain | EGF | SNED1 FBLN2 STAB2 NRXN3 NRXN2 LAMA1 WIF1 TECTA ADGRE1 MEGF11 CRB1 | 4.74e-11 | 235 | 53 | 11 | SM00181 |
| Domain | EGF-like_dom | SNED1 FBLN2 STAB2 NRXN3 NRXN2 LAMA1 WIF1 TECTA ADGRE1 MEGF11 CRB1 | 8.82e-11 | 249 | 53 | 11 | IPR000742 |
| Domain | ADH_Zn_CS | 4.01e-09 | 8 | 53 | 4 | IPR002328 | |
| Domain | ADH_ZINC | 4.01e-09 | 8 | 53 | 4 | PS00059 | |
| Domain | EGF_3 | 1.86e-08 | 235 | 53 | 9 | PS50026 | |
| Domain | EGF_Lam | 4.61e-08 | 35 | 53 | 5 | SM00180 | |
| Domain | EGF | 6.41e-08 | 126 | 53 | 7 | PF00008 | |
| Domain | Laminin_EGF | 7.09e-08 | 38 | 53 | 5 | IPR002049 | |
| Domain | ADH_N | 1.03e-07 | 16 | 53 | 4 | PF08240 | |
| Domain | ADH_N | 1.03e-07 | 16 | 53 | 4 | IPR013154 | |
| Domain | - | 1.72e-07 | 18 | 53 | 4 | 3.90.180.10 | |
| Domain | ADH_zinc_N | 2.17e-07 | 19 | 53 | 4 | PF00107 | |
| Domain | ADH_SF_Zn-type | 2.17e-07 | 19 | 53 | 4 | IPR002085 | |
| Domain | ADH_C | 2.17e-07 | 19 | 53 | 4 | IPR013149 | |
| Domain | Growth_fac_rcpt_ | 2.77e-07 | 156 | 53 | 7 | IPR009030 | |
| Domain | GroES-like | 5.89e-07 | 24 | 53 | 4 | IPR011032 | |
| Domain | hEGF | 1.12e-06 | 28 | 53 | 4 | PF12661 | |
| Domain | EGF_LAM_2 | 1.50e-06 | 30 | 53 | 4 | PS50027 | |
| Domain | EGF_LAM_1 | 1.50e-06 | 30 | 53 | 4 | PS01248 | |
| Domain | Laminin_EGF | 2.83e-06 | 35 | 53 | 4 | PF00053 | |
| Domain | LAM_G_DOMAIN | 3.97e-06 | 38 | 53 | 4 | PS50025 | |
| Domain | Laminin_G_2 | 4.90e-06 | 40 | 53 | 4 | PF02210 | |
| Domain | LamG | 7.21e-06 | 44 | 53 | 4 | SM00282 | |
| Domain | ASX_HYDROXYL | 9.31e-06 | 100 | 53 | 5 | PS00010 | |
| Domain | Laminin_N | 1.18e-05 | 16 | 53 | 3 | IPR008211 | |
| Domain | PKS_ER | 1.18e-05 | 16 | 53 | 3 | SM00829 | |
| Domain | LAMININ_NTER | 1.18e-05 | 16 | 53 | 3 | PS51117 | |
| Domain | Laminin_N | 1.18e-05 | 16 | 53 | 3 | PF00055 | |
| Domain | PKS_ER | 1.18e-05 | 16 | 53 | 3 | IPR020843 | |
| Domain | LamNT | 1.18e-05 | 16 | 53 | 3 | SM00136 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 1.24e-05 | 106 | 53 | 5 | IPR000152 | |
| Domain | Laminin_G | 2.19e-05 | 58 | 53 | 4 | IPR001791 | |
| Domain | EGF_CA | 2.45e-05 | 122 | 53 | 5 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 2.65e-05 | 124 | 53 | 5 | IPR001881 | |
| Domain | ConA-like_dom | 3.52e-05 | 219 | 53 | 6 | IPR013320 | |
| Domain | NIDO_dom | 7.86e-05 | 5 | 53 | 2 | IPR003886 | |
| Domain | NIDO | 7.86e-05 | 5 | 53 | 2 | SM00539 | |
| Domain | NIDO | 7.86e-05 | 5 | 53 | 2 | PF06119 | |
| Domain | NIDO | 7.86e-05 | 5 | 53 | 2 | PS51220 | |
| Domain | - | 1.52e-04 | 95 | 53 | 4 | 2.60.120.200 | |
| Domain | Syndecan | 1.64e-04 | 7 | 53 | 2 | PF01034 | |
| Domain | Syndecan/Neurexin_dom | 1.64e-04 | 7 | 53 | 2 | IPR027789 | |
| Domain | EGF_Ca-bd_CS | 1.65e-04 | 97 | 53 | 4 | IPR018097 | |
| Domain | EGF_CA | 1.78e-04 | 99 | 53 | 4 | PS01187 | |
| Domain | PMG | 6.04e-04 | 13 | 53 | 2 | PF05287 | |
| Domain | KRTAP_PMG | 6.04e-04 | 13 | 53 | 2 | IPR007951 | |
| Domain | EGF_extracell | 6.59e-04 | 60 | 53 | 3 | IPR013111 | |
| Domain | EGF_2 | 6.59e-04 | 60 | 53 | 3 | PF07974 | |
| Domain | PLAC | 7.03e-04 | 14 | 53 | 2 | PF08686 | |
| Domain | Neurexin-like | 7.03e-04 | 14 | 53 | 2 | IPR003585 | |
| Domain | 4.1m | 7.03e-04 | 14 | 53 | 2 | SM00294 | |
| Domain | TSP_1 | 7.60e-04 | 63 | 53 | 3 | PF00090 | |
| Domain | TSP1 | 8.32e-04 | 65 | 53 | 3 | SM00209 | |
| Domain | TSP1_rpt | 8.32e-04 | 65 | 53 | 3 | IPR000884 | |
| Domain | TSP1 | 8.32e-04 | 65 | 53 | 3 | PS50092 | |
| Domain | PLAC | 1.31e-03 | 19 | 53 | 2 | PS50900 | |
| Domain | PLAC | 1.31e-03 | 19 | 53 | 2 | IPR010909 | |
| Domain | - | 1.34e-03 | 169 | 53 | 4 | 3.40.50.720 | |
| Domain | ZINC_FINGER_C2H2_2 | 1.44e-03 | 775 | 53 | 8 | PS50157 | |
| Domain | ZINC_FINGER_C2H2_1 | 1.46e-03 | 777 | 53 | 8 | PS00028 | |
| Domain | NAD(P)-bd_dom | 1.46e-03 | 173 | 53 | 4 | IPR016040 | |
| Domain | Znf_C2H2-like | 1.70e-03 | 796 | 53 | 8 | IPR015880 | |
| Domain | Znf_C2H2 | 1.83e-03 | 805 | 53 | 8 | IPR007087 | |
| Domain | ZnF_C2H2 | 1.87e-03 | 808 | 53 | 8 | SM00355 | |
| Domain | ADAM_spacer1 | 1.92e-03 | 23 | 53 | 2 | IPR010294 | |
| Domain | ADAM_spacer1 | 1.92e-03 | 23 | 53 | 2 | PF05986 | |
| Domain | Peptidase_M12B_ADAM-TS | 2.10e-03 | 24 | 53 | 2 | IPR013273 | |
| Domain | Galactose-bd-like | 2.41e-03 | 94 | 53 | 3 | IPR008979 | |
| Domain | cEGF | 2.46e-03 | 26 | 53 | 2 | IPR026823 | |
| Domain | cEGF | 2.46e-03 | 26 | 53 | 2 | PF12662 | |
| Domain | zf-C2H2 | 3.28e-03 | 693 | 53 | 7 | PF00096 | |
| Domain | GPS | 4.18e-03 | 34 | 53 | 2 | SM00303 | |
| Domain | GPCR_2_secretin-like_CS | 4.18e-03 | 34 | 53 | 2 | IPR017983 | |
| Domain | GPS | 4.43e-03 | 35 | 53 | 2 | PF01825 | |
| Domain | GPS | 4.68e-03 | 36 | 53 | 2 | PS50221 | |
| Domain | GPS | 4.94e-03 | 37 | 53 | 2 | IPR000203 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 2.05e-08 | 10 | 46 | 4 | MM15833 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 3.22e-08 | 11 | 46 | 4 | MM15405 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 4.82e-08 | 12 | 46 | 4 | M14663 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 1.32e-07 | 15 | 46 | 4 | M39717 | |
| Pathway | REACTOME_ABACAVIR_ADME | 1.80e-06 | 8 | 46 | 3 | MM14869 | |
| Pathway | KEGG_FATTY_ACID_METABOLISM | 1.01e-05 | 42 | 46 | 4 | M699 | |
| Pathway | KEGG_TYROSINE_METABOLISM | 1.01e-05 | 42 | 46 | 4 | M16743 | |
| Pathway | KEGG_GLYCOLYSIS_GLUCONEOGENESIS | 4.82e-05 | 62 | 46 | 4 | M11521 | |
| Pathway | KEGG_RETINOL_METABOLISM | 5.46e-05 | 64 | 46 | 4 | M9488 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 7.77e-05 | 70 | 46 | 4 | M16794 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 8.68e-05 | 72 | 46 | 4 | M9257 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 1.01e-04 | 28 | 46 | 3 | MM15188 | |
| Pathway | WP_ETHANOL_EFFECTS_ON_HISTONE_MODIFICATIONS | 1.37e-04 | 31 | 46 | 3 | M39714 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 1.51e-04 | 32 | 46 | 3 | MM15326 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.74e-04 | 39 | 46 | 3 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 2.74e-04 | 39 | 46 | 3 | MM15165 | |
| Pathway | WP_AMINO_ACID_METABOLISM | 2.86e-04 | 98 | 46 | 4 | MM15942 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 3.60e-04 | 104 | 46 | 4 | M738 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 3.73e-04 | 105 | 46 | 4 | MM14842 | |
| Pathway | WP_RETINOL_METABOLISM | 3.92e-04 | 44 | 46 | 3 | MM15851 | |
| Pathway | REACTOME_SIGNALING_BY_RETINOIC_ACID | 5.39e-04 | 49 | 46 | 3 | MM15186 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 7.99e-04 | 56 | 46 | 3 | M27616 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 1.12e-03 | 502 | 46 | 7 | MM14537 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 1.35e-03 | 67 | 46 | 3 | MM15327 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 1.40e-03 | 68 | 46 | 3 | M27303 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 2.31e-03 | 22 | 46 | 2 | M27445 | |
| Pathway | REACTOME_NERVOUS_SYSTEM_DEVELOPMENT | 2.43e-03 | 575 | 46 | 7 | M29853 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 2.85e-03 | 87 | 46 | 3 | M27617 | |
| Pathway | WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS | 3.47e-03 | 27 | 46 | 2 | M45550 | |
| Pubmed | 5.19e-12 | 4 | 54 | 4 | 9241435 | ||
| Pubmed | 5.19e-12 | 4 | 54 | 4 | 2893758 | ||
| Pubmed | 5.19e-12 | 4 | 54 | 4 | 9733106 | ||
| Pubmed | 5.19e-12 | 4 | 54 | 4 | 9202249 | ||
| Pubmed | 5.19e-12 | 4 | 54 | 4 | 9002638 | ||
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 8892527 | ||
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 11836246 | ||
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 8621625 | ||
| Pubmed | Adh1 and Adh1/4 knockout mice as possible rodent models for presymptomatic Parkinson's disease. | 2.59e-11 | 5 | 54 | 4 | 22079585 | |
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 7026729 | ||
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 10358022 | ||
| Pubmed | 2.59e-11 | 5 | 54 | 4 | 7738026 | ||
| Pubmed | ADH single nucleotide polymorphism associations with alcohol metabolism in vivo. | 2.59e-11 | 5 | 54 | 4 | 19193628 | |
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 17257171 | ||
| Pubmed | Human liver alcohol dehydrogenase: purification, composition, and catalytic features. | 7.76e-11 | 6 | 54 | 4 | 9982 | |
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 518534 | ||
| Pubmed | Multiple ADH genes modulate risk for drug dependence in both African- and European-Americans. | 7.76e-11 | 6 | 54 | 4 | 17185388 | |
| Pubmed | 7.76e-11 | 6 | 54 | 4 | 12027900 | ||
| Pubmed | 1.81e-10 | 7 | 54 | 4 | 16047160 | ||
| Pubmed | 1.81e-10 | 7 | 54 | 4 | 11784316 | ||
| Pubmed | 1.81e-10 | 7 | 54 | 4 | 16685648 | ||
| Pubmed | 1.81e-10 | 7 | 54 | 4 | 23456092 | ||
| Pubmed | Association between common alcohol dehydrogenase gene (ADH) variants and schizophrenia and autism. | 1.81e-10 | 7 | 54 | 4 | 23468174 | |
| Pubmed | 3.62e-10 | 8 | 54 | 4 | 18331377 | ||
| Pubmed | 6.50e-10 | 9 | 54 | 4 | 11747070 | ||
| Pubmed | 2.54e-09 | 12 | 54 | 4 | 12128098 | ||
| Pubmed | Short-term selective breeding as a tool for QTL mapping: ethanol preference drinking in mice. | 3.54e-09 | 3 | 54 | 3 | 9145544 | |
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 3428612 | ||
| Pubmed | Genetic and developmental regulation of mouse liver alcohol dehydrogenase. | 3.54e-09 | 3 | 54 | 3 | 6816803 | |
| Pubmed | Recommended nomenclature for the vertebrate alcohol dehydrogenase gene family. | 3.54e-09 | 3 | 54 | 3 | 10424757 | |
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 11960985 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 2474823 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 2737681 | ||
| Pubmed | Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. | 3.54e-09 | 3 | 54 | 3 | 15670660 | |
| Pubmed | Regulation of human class I alcohol dehydrogenases by bile acids. | 3.54e-09 | 3 | 54 | 3 | 23772048 | |
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 8163197 | ||
| Pubmed | ALDH expression characterizes G1-phase proliferating beta cells during pregnancy. | 3.54e-09 | 3 | 54 | 3 | 24787690 | |
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 8973327 | ||
| Pubmed | The discovery of the microsomal ethanol oxidizing system and its physiologic and pathologic role. | 3.54e-09 | 3 | 54 | 3 | 15554233 | |
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 35354963 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 6370228 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 8018987 | ||
| Pubmed | Paracardial fat remodeling affects systemic metabolism through alcohol dehydrogenase 1. | 3.54e-09 | 3 | 54 | 3 | 33586683 | |
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 2347582 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 3011597 | ||
| Pubmed | Cloning and sequencing of cDNA encoding the complete mouse liver alcohol dehydrogenase. | 3.54e-09 | 3 | 54 | 3 | 3157987 | |
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 6756216 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 2169444 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 17326332 | ||
| Pubmed | The role of alcohol dehydrogenase in retinoic acid homeostasis and fetal alcohol syndrome. | 3.54e-09 | 3 | 54 | 3 | 7748347 | |
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 37806378 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 7840644 | ||
| Pubmed | A novel negative element in the promoter of the mouse alcohol dehydrogenase gene Adh-1. | 3.54e-09 | 3 | 54 | 3 | 8486690 | |
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 3006456 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 24722735 | ||
| Pubmed | 3.54e-09 | 3 | 54 | 3 | 2935875 | ||
| Pubmed | Individual susceptibility and alcohol effects:biochemical and genetic aspects. | 3.54e-09 | 3 | 54 | 3 | 16801720 | |
| Pubmed | Confirmation of quantitative trait loci for alcohol preference in mice. | 6.99e-09 | 15 | 54 | 4 | 9726281 | |
| Pubmed | 9.31e-09 | 16 | 54 | 4 | 15765518 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 19618839 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 11893554 | ||
| Pubmed | Mouse mitochondrial aldehyde dehydrogenase isozymes: purification and molecular properties. | 1.41e-08 | 4 | 54 | 3 | 3996732 | |
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 29663519 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 10880953 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 12631290 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 12851412 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 36224745 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 8813054 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 15193143 | ||
| Pubmed | 1.41e-08 | 4 | 54 | 3 | 19687126 | ||
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 20700531 | ||
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 19861527 | ||
| Pubmed | 3.53e-08 | 5 | 54 | 3 | 1316195 | ||
| Pubmed | Merging protein, gene and genomic data: the evolution of the MDR-ADH family. | 7.05e-08 | 6 | 54 | 3 | 16121213 | |
| Pubmed | 7.05e-08 | 6 | 54 | 3 | 26807981 | ||
| Pubmed | 1.23e-07 | 7 | 54 | 3 | 37953328 | ||
| Pubmed | Androgen regulation of gene expression in primary epithelial cells of the mouse kidney. | 1.23e-07 | 7 | 54 | 3 | 8119157 | |
| Pubmed | 1.81e-07 | 32 | 54 | 4 | 17270348 | ||
| Pubmed | 1.97e-07 | 8 | 54 | 3 | 21437268 | ||
| Pubmed | 1.97e-07 | 8 | 54 | 3 | 7937138 | ||
| Pubmed | 1.97e-07 | 8 | 54 | 3 | 2040456 | ||
| Pubmed | 2.95e-07 | 9 | 54 | 3 | 93520 | ||
| Pubmed | 5.79e-07 | 11 | 54 | 3 | 2565740 | ||
| Pubmed | Differential gene expression in the developing mouse ureter. | 7.71e-07 | 12 | 54 | 3 | 16459152 | |
| Pubmed | Murine Models of Acute Alcoholic Hepatitis and Their Relevance to Human Disease. | 1.27e-06 | 14 | 54 | 3 | 26835538 | |
| Pubmed | 1.27e-06 | 14 | 54 | 3 | 2902233 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 8201622 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 29390059 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 25503943 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 24735490 | ||
| Pubmed | Alcoholism and alcohol drinking habits predicted from alcohol dehydrogenase genes. | 2.37e-06 | 2 | 54 | 2 | 17923853 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 29058369 | ||
| Pubmed | Three-dimensional structures of the three human class I alcohol dehydrogenases. | 2.37e-06 | 2 | 54 | 2 | 11274460 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 20031627 | ||
| Pubmed | Alcohol drinking habits, alcohol dehydrogenase genotypes and risk of acute coronary syndrome. | 2.37e-06 | 2 | 54 | 2 | 20494945 | |
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 3397059 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 30052783 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 26042511 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 1896463 | ||
| Pubmed | 2.37e-06 | 2 | 54 | 2 | 25874489 | ||
| Interaction | ADH1B interactions | 5.10e-06 | 13 | 54 | 3 | int:ADH1B | |
| Interaction | ZNF628 interactions | 9.94e-06 | 16 | 54 | 3 | int:ZNF628 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q23 | 1.02e-07 | 37 | 53 | 4 | chr4q23 | |
| Cytoband | 4q23 | 1.63e-06 | 20 | 53 | 3 | 4q23 | |
| Cytoband | 21q22.1 | 9.43e-04 | 39 | 53 | 2 | 21q22.1 | |
| Cytoband | 2q37.3 | 3.62e-03 | 77 | 53 | 2 | 2q37.3 | |
| GeneFamily | Alcohol dehydrogenases | 1.93e-09 | 8 | 43 | 4 | 397 | |
| GeneFamily | ADAMTS like | 1.15e-04 | 7 | 43 | 2 | 947 | |
| GeneFamily | Laminin subunits | 3.59e-04 | 12 | 43 | 2 | 626 | |
| GeneFamily | C2-set domain containing|Immunoglobulin like domain containing|Scavenger receptors | 1.87e-03 | 27 | 43 | 2 | 1253 | |
| GeneFamily | Keratin associated proteins | 2.21e-03 | 109 | 43 | 3 | 619 | |
| GeneFamily | Fibronectin type III domain containing | 6.48e-03 | 160 | 43 | 3 | 555 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | 6.69e-03 | 718 | 43 | 6 | 28 | |
| GeneFamily | Sterile alpha motif domain containing | 1.86e-02 | 88 | 43 | 2 | 760 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 1.35e-07 | 196 | 53 | 7 | M3008 | |
| Coexpression | BROWNE_HCMV_INFECTION_2HR_UP | 1.29e-06 | 40 | 53 | 4 | M3649 | |
| Coexpression | NABA_CORE_MATRISOME | 1.32e-06 | 275 | 53 | 7 | M5884 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | 2.39e-06 | 191 | 53 | 6 | MM17059 | |
| Coexpression | AIZARANI_LIVER_C9_LSECS_1 | 2.57e-06 | 304 | 53 | 7 | M39113 | |
| Coexpression | NABA_MATRISOME | THSD4 SNED1 NTN4 LAMB4 ADAMTSL1 FBLN2 ADAMTS9 LAMA1 WIF1 TECTA MEGF11 | 5.28e-06 | 1026 | 53 | 11 | M5889 |
| Coexpression | LAKE_ADULT_KIDNEY_C22_ENDOTHELIAL_CELLS_GLOMERULAR_CAPILLARIES | 8.50e-06 | 137 | 53 | 5 | M39241 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 1.66e-05 | 268 | 53 | 6 | M45796 | |
| Coexpression | NABA_CORE_MATRISOME | 1.73e-05 | 270 | 53 | 6 | MM17057 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | 2.10e-05 | 767 | 53 | 9 | M39209 | |
| Coexpression | AIZARANI_LIVER_C13_LSECS_2 | 2.25e-05 | 283 | 53 | 6 | M39117 | |
| Coexpression | AIZARANI_LIVER_C20_LSECS_3 | 2.84e-05 | 295 | 53 | 6 | M39121 | |
| Coexpression | NABA_MATRISOME | THSD4 SNED1 NTN4 ADAMTSL1 FBLN2 ADAMTS9 LAMA1 WIF1 TECTA MEGF11 | 2.93e-05 | 1008 | 53 | 10 | MM17056 |
| Coexpression | WANG_MLL_TARGETS | 3.49e-05 | 306 | 53 | 6 | MM1076 | |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | 3.64e-05 | 630 | 53 | 8 | MM1038 | |
| Coexpression | GSE26495_NAIVE_VS_PD1HIGH_CD8_TCELL_UP | 4.43e-05 | 193 | 53 | 5 | M4654 | |
| Coexpression | IVANOVA_HEMATOPOIESIS_STEM_CELL | 4.76e-05 | 196 | 53 | 5 | MM667 | |
| Coexpression | NABA_MATRISOME_POORLY_METASTATIC_MELANOMA | 6.26e-05 | 38 | 53 | 3 | M47982 | |
| Coexpression | GAVIN_FOXP3_TARGETS_CLUSTER_P4 | 6.35e-05 | 106 | 53 | 4 | MM1216 | |
| Coexpression | LEIN_CHOROID_PLEXUS_MARKERS | 7.08e-05 | 109 | 53 | 4 | MM1214 | |
| Coexpression | NABA_BASEMENT_MEMBRANES | 7.32e-05 | 40 | 53 | 3 | M5887 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN | 1.11e-04 | 8 | 53 | 2 | M9012 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_DN | 1.11e-04 | 8 | 53 | 2 | MM478 | |
| Coexpression | VECCHI_GASTRIC_CANCER_EARLY_DN | 1.19e-04 | 382 | 53 | 6 | M15472 | |
| Coexpression | MCDOWELL_ACUTE_LUNG_INJURY_DN | 1.61e-04 | 52 | 53 | 3 | MM693 | |
| Coexpression | LEE_BMP2_TARGETS_UP | 1.99e-04 | 805 | 53 | 8 | MM1067 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_MID_BASAL_CELL | 2.37e-04 | 149 | 53 | 4 | M45703 | |
| Coexpression | LAKE_ADULT_KIDNEY_C20_COLLECTING_DUCT_INTERCALATED_CELLS_TYPE_A_CORTEX | 2.55e-04 | 152 | 53 | 4 | M39239 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | 2.75e-04 | 1074 | 53 | 9 | M1941 | |
| Coexpression | TABULA_MURIS_SENIS_PANCREAS_PANCREATIC_DUCTAL_CELL_AGEING | 3.02e-04 | 291 | 53 | 5 | MM3820 | |
| Coexpression | CASTELLANO_NRAS_TARGETS_DN | 3.59e-04 | 14 | 53 | 2 | M12848 | |
| Coexpression | CASTELLANO_NRAS_TARGETS_DN | 3.59e-04 | 14 | 53 | 2 | MM468 | |
| Coexpression | BURTON_ADIPOGENESIS_PEAK_AT_0HR | 3.72e-04 | 69 | 53 | 3 | MM1024 | |
| Coexpression | LAKE_ADULT_KIDNEY_C11_THIN_ASCENDING_LIMB | 3.82e-04 | 169 | 53 | 4 | M39230 | |
| Coexpression | AIZARANI_LIVER_C29_MVECS_2 | 4.22e-04 | 313 | 53 | 5 | M39128 | |
| Coexpression | VERHAAK_GLIOBLASTOMA_PRONEURAL | 4.55e-04 | 177 | 53 | 4 | M2115 | |
| Coexpression | ATF2_S_UP.V1_DN | 5.59e-04 | 187 | 53 | 4 | M2681 | |
| ToppCell | COVID-19-Neuronal_cells-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 2.33e-09 | 185 | 53 | 7 | 4a095829992b39856a73bdfac03ee68b9aa0d3b8 | |
| ToppCell | COVID-19-Neuronal_cells|COVID-19 / group, cell type (main and fine annotations) | 2.33e-09 | 185 | 53 | 7 | 36ce23893915f5c380cca39b2c33a516edf31c3a | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 3.13e-09 | 193 | 53 | 7 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | RV-10._Endothelium_II|World / Chamber and Cluster_Paper | 3.13e-09 | 193 | 53 | 7 | 2531266bc57339d4e2b22a88817008e32b8c1598 | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 9.89e-08 | 189 | 53 | 6 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | background-Endothelial_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 1.23e-07 | 196 | 53 | 6 | e6fb0bfab1779ec64a8c35d01519eaafbf62e977 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-07 | 197 | 53 | 6 | d584d0334ea97e3fa8c4cd869f5eeea2c7a1ed04 | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-07 | 197 | 53 | 6 | 412091994196a06c2779b4c2cfed84be889a5f8d | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.34e-07 | 199 | 53 | 6 | 41f046646fff65b7e51b63d3204f76ef32054781 | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.34e-07 | 199 | 53 | 6 | ef7f7f7c861827574b120f48cf4052c563929081 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.38e-07 | 200 | 53 | 6 | 032df80aa5c40991e1c1e80f9d8da106e6aeaee2 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.38e-07 | 200 | 53 | 6 | 68fce28690246895fd33354b30960ebcc31aa4cc | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.38e-07 | 200 | 53 | 6 | 376b19ab5a7cd2c85f726d8ba41337d4525863e5 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.38e-07 | 200 | 53 | 6 | 7fa54370221ed61bac0e09e6bcf1f3dff202a846 | |
| ToppCell | Hematolymphoid-Endothelial-NOSTRIN----L2-6|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.38e-07 | 200 | 53 | 6 | 878bbbe32e3602723aa14ef32877ab2453b8c6e5 | |
| ToppCell | Hematolymphoid-Endothelial|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.38e-07 | 200 | 53 | 6 | 7136936d05ab344a560cf159684c881063b5430d | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_B|E18.5-samps / Age Group, Lineage, Cell class and subclass | 6.21e-07 | 137 | 53 | 5 | b553958e7e6dcd887d860e34d3983cbb85cefaa6 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.75e-06 | 169 | 53 | 5 | 2456b3e7776e8a2214972be1b4d66a3ca5480ae0 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-06 | 172 | 53 | 5 | e37c0b5b547a7345179ab258dd2141fec7064c17 | |
| ToppCell | droplet-Marrow-BM_(NON-STC)-30m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-06 | 172 | 53 | 5 | 7295bf3ae21a61dd6bcfa0dfb7a37d0f3e8f94ab | |
| ToppCell | Endothelial-Endothelial-G|Endothelial / shred on cell class and cell subclass (v4) | 1.91e-06 | 172 | 53 | 5 | 644f8e42ee8d8996f6ae50cdf874559be55509fc | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.45e-06 | 181 | 53 | 5 | 098dbb3e0ff531c9720a233123250c1e39a97d4c | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-MatrixFB_->_Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.58e-06 | 183 | 53 | 5 | 7eae9b3b4d1c9b135fa7cff348393d4adec474b4 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.72e-06 | 185 | 53 | 5 | a7dba7db79275884b2a93d8a16f2e0c739e71370 | |
| ToppCell | LV-10._Endothelium_II|World / Chamber and Cluster_Paper | 2.87e-06 | 187 | 53 | 5 | 7876dcb4800c2e54874df3d933efb79307a64a97 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.87e-06 | 187 | 53 | 5 | 5d3d68519c8e19f10c29f9d81712125be78ca15a | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.87e-06 | 187 | 53 | 5 | 5c73010fe4c85fb5cc1273f5504821229ca0cc4b | |
| ToppCell | COPD-Stromal-Pericyte|Stromal / Disease state, Lineage and Cell class | 2.87e-06 | 187 | 53 | 5 | 406ecd1dabb3ed8d871aef159f7bd1e383434953 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.87e-06 | 187 | 53 | 5 | 93c78fc7f126132eb84feb47be2c4e8c568b9e91 | |
| ToppCell | Somatosensory_Cortex_(S1)-Non-neuronal-Macroglial-Astro-Astrocyte-Astro_L1-6_FGFR3_ETNPPL|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 3.10e-06 | 190 | 53 | 5 | b56c55f608b30f7379941ac7d5f0f5200f305fca | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.10e-06 | 190 | 53 | 5 | 6b704deeb44e1ffa10e604d0e5612b022f6cd9a6 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.18e-06 | 191 | 53 | 5 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.18e-06 | 191 | 53 | 5 | dc9e5eb6aa31b8d79aeec33e59b9138dfb469a3b | |
| ToppCell | 3'-Child09-12-SmallIntestine-Neuronal-Glial_mature|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.26e-06 | 192 | 53 | 5 | ac507fd7cf3b3e521a15ef03bb4e81eb23807985 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Neuronal|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.26e-06 | 192 | 53 | 5 | 24f40dadec04f4f99c31000fa9f09d07148fa190 | |
| ToppCell | 3'-Child09-12-SmallIntestine-Neuronal-Glial_mature-Adult_Glia|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.26e-06 | 192 | 53 | 5 | 71e04e197825856c6d4278fc76c58ab17ffa2387 | |
| ToppCell | COPD-Endothelial-VE_Arterial|COPD / Disease state, Lineage and Cell class | 3.35e-06 | 193 | 53 | 5 | 1c701b6ab5f0f0239634adac94fa1c92bf3c36f4 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Activated_Alv_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.35e-06 | 193 | 53 | 5 | a3636c35ed25aabe2f1aba016c9fe125327bbfaf | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2|World / Primary Cells by Cluster | 3.43e-06 | 194 | 53 | 5 | b42fd64b0fb95434a9e4e6586f31d26114a4074b | |
| ToppCell | Neuron-Postmitotic-Inhibitory_Neuron-MGE2-10|World / Primary Cells by Cluster | 3.43e-06 | 194 | 53 | 5 | 81e7bc6516ab8d02ccd1c76a56a3533b788c27c8 | |
| ToppCell | LV-10._Endothelium_II|LV / Chamber and Cluster_Paper | 3.43e-06 | 194 | 53 | 5 | b6cc849fa08599bff9839ef382d190cc964e273e | |
| ToppCell | 10x5'v1-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.43e-06 | 194 | 53 | 5 | e141beafc9252e5d8c949252bfab53e127c881dc | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.43e-06 | 194 | 53 | 5 | 953578102ffc7b612ee8fce45e414750800fef5d | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-06 | 194 | 53 | 5 | 90efdbd7f1c85fd7fd622b10340250b1d8fc1197 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.43e-06 | 194 | 53 | 5 | df82cce5ebeb73740b02cf816c6df82253cfd566 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.52e-06 | 195 | 53 | 5 | 22a481927147ec4ae9d59e6af7c87df0e9cb51e4 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.61e-06 | 196 | 53 | 5 | 2b36b9a40fe415917afccff99ad9c3474e087d0d | |
| ToppCell | facs-Liver-Liver_non-hepato/SCs-18m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.61e-06 | 196 | 53 | 5 | 81900dcc9451ff6606ec940c16b559d73247590e | |
| ToppCell | 10x3'2.3-week_14-16-Endothelial-stroma-sinusoidal_EC|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.70e-06 | 197 | 53 | 5 | f1080d93acf1a4756d2f2c8cabd1fb50bc7bcd09 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Mesofibroblastic|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.70e-06 | 197 | 53 | 5 | d7cef7881abd807a679432766ced609a6efd1067 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma-sinusoidal_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.70e-06 | 197 | 53 | 5 | 4e58bbf3ecb30b4c8199adcc04d2eb134d90de56 | |
| ToppCell | Bronchus_Control_(B.)-Epithelial-TX-AT1|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 3.70e-06 | 197 | 53 | 5 | f7ef62d78336812573148f8bfce401877ec4e29c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 3.70e-06 | 197 | 53 | 5 | 80e153790cef37b743e22a7370ff5b3a6abf147d | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Mesofibroblastic-Mesothelia|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 3.70e-06 | 197 | 53 | 5 | 20a5958512bdb99daeb8f4d244df53e4f048f879 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.79e-06 | 198 | 53 | 5 | 2630a7a6e56febe5c0b0bde70dd7292fa1650c47 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Neuronal-Glial_immature-Glia_2_(ELN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.79e-06 | 198 | 53 | 5 | 52ddc1f1ed4ac4c3bac794c90b8feb03e3c221c4 | |
| ToppCell | 10x3'2.3-week_17-19-Endothelial-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 3.79e-06 | 198 | 53 | 5 | 1e83bec16dcd60460422625f89952ff506d6be51 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.89e-06 | 199 | 53 | 5 | a76aa30fb264bdcbc0cb09113f814fc5a89e7319 | |
| ToppCell | Endothelial-G|World / shred on cell class and cell subclass (v4) | 1.45e-05 | 124 | 53 | 4 | 4b72809463f2986b7d1b7ab9de633ac4d7854a92 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-Intermediate_Fibroblast|E16.5-samps / Age Group, Lineage, Cell class and subclass | 2.15e-05 | 137 | 53 | 4 | dd5364a1002650d21e0c83d8c701b5f7b09d1c19 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-05 | 160 | 53 | 4 | c381ec6be8cf887861cc18f831a20db42f953fe1 | |
| ToppCell | facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-05 | 160 | 53 | 4 | 25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-05 | 160 | 53 | 4 | 0544bc465af208da448858d6e174ff56f2e08a46 | |
| ToppCell | PND10-Immune-Immune_Myeloid-Monocytic-Macrophage-IM-IM_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.03e-05 | 161 | 53 | 4 | 8937f6b92cb2a93ea8c4780d9200a518c3112e53 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.34e-05 | 164 | 53 | 4 | 4cfc9f92e49f86d3639e018b35b6a60dc62f494a | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.34e-05 | 164 | 53 | 4 | 7a8e5ef52a8fd2877d59ef0696af8a7af90bbed6 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.34e-05 | 164 | 53 | 4 | 5e5bd81414ea2d64f73cdef19a0a78c17bec8c18 | |
| ToppCell | PND10-Endothelial-Endothelial_lymphatic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 4.34e-05 | 164 | 53 | 4 | f13b8d9b7f42193f333d9a77571a1dde6bbb48d8 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.55e-05 | 166 | 53 | 4 | 5ba45407a47207ff01e4a3f9f5d91d8247fe9b6f | |
| ToppCell | droplet-Marrow-nan-21m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.55e-05 | 166 | 53 | 4 | 91eeb48680dd07ae4115afacdc0a8f6fa18885e5 | |
| ToppCell | droplet-Marrow-nan-24m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.55e-05 | 166 | 53 | 4 | b3d9b61847c6c96b8cb28b8a6aeda52f43c706ab | |
| ToppCell | 356C-Endothelial_cells-Endothelial-F_(Lymphatics)|356C / Donor, Lineage, Cell class and subclass (all cells) | 4.55e-05 | 166 | 53 | 4 | 6bd5aa205b6e4b88ba9f8cd0999e2191d7d1d16c | |
| ToppCell | TCGA-Head_and_Esophagus-Solid_Tissue_Normal-Head_and_Neck-Head_and_Neck_normal_tissue-6|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9 | 4.65e-05 | 167 | 53 | 4 | 4a533972a0f40fff82dccf8e64716cb34f75736e | |
| ToppCell | Hippocampus-Endothelial-ENDOTHELIAL_TIP|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 4.76e-05 | 168 | 53 | 4 | 26aa96b2b547d11941cb803995ea3d302ee0518c | |
| ToppCell | TCGA-Colorectal-Solid_Tissue_Normal-Rectum_normal_tissue-Rectum_normal_tissue-6|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 4.76e-05 | 168 | 53 | 4 | 5ce3129a023a48a3d7e6b9306c1fc5addfef9675 | |
| ToppCell | LA-16._Neuronal|World / Chamber and Cluster_Paper | 4.76e-05 | 168 | 53 | 4 | 2fd1fd2a16ac1c5eb028f93cc3a2477c7747693e | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 4.76e-05 | 168 | 53 | 4 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | LA-16._Neuronal|LA / Chamber and Cluster_Paper | 4.76e-05 | 168 | 53 | 4 | c55bbfbde8bb954f1cb9af82007bdd1f8070fee3 | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue|TCGA-Stomach / Sample_Type by Project: Shred V9 | 5.10e-05 | 171 | 53 | 4 | 0f8d038858a4618b4348becc26a618d43b10d9d6 | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal|TCGA-Stomach / Sample_Type by Project: Shred V9 | 5.10e-05 | 171 | 53 | 4 | 791d37fe94ff2820fb409bbd38b31799df700ba1 | |
| ToppCell | TCGA-Stomach-Solid_Tissue_Normal-Stomach_normal_tissue-Stomach_normal_tissue|TCGA-Stomach / Sample_Type by Project: Shred V9 | 5.10e-05 | 171 | 53 | 4 | 0bf36930bd7fc63691f48a15db93deb1dd937c10 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue-3|TCGA-Breast / Sample_Type by Project: Shred V9 | 5.46e-05 | 174 | 53 | 4 | 7f8f5fafae08676d2b90cab9802c3c9320f1370e | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal|TCGA-Breast / Sample_Type by Project: Shred V9 | 5.46e-05 | 174 | 53 | 4 | e2f240d60bffbe8e6d60f0bb405b231bd3c96875 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue|TCGA-Breast / Sample_Type by Project: Shred V9 | 5.46e-05 | 174 | 53 | 4 | 0f3ec0d0d4344e10c9b48adc9174123f6402dc51 | |
| ToppCell | facs-Heart-RA-24m-Endothelial-endothelial_cell_of_endocardium|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-05 | 174 | 53 | 4 | 42dfb6f42b72e40e203b3ef341117bccf3553d54 | |
| ToppCell | TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue|TCGA-Breast / Sample_Type by Project: Shred V9 | 5.46e-05 | 174 | 53 | 4 | 1aadbf2642b6d1320ceabd92e6ff59e11f16c315 | |
| ToppCell | facs-Heart-RA-24m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.46e-05 | 174 | 53 | 4 | f04edf2ca6788875c9918611e416fb739924382e | |
| ToppCell | Control-Neuronal_cells-Neuronal_cells|Control / group, cell type (main and fine annotations) | 5.71e-05 | 176 | 53 | 4 | 98c07d26ba0dc0fe15ca0ea81f633d4591782bd1 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)-|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.71e-05 | 176 | 53 | 4 | 2e94bbe17c0bb65dc58b4ebc0cb829258bd7373b | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Dendritic-DC2|lymph-node_spleen / Manually curated celltypes from each tissue | 5.71e-05 | 176 | 53 | 4 | 72a3bbab0540ae3e3c94b9573cdb9298a024dbc4 | |
| ToppCell | Control-Neuronal_cells|Control / group, cell type (main and fine annotations) | 5.71e-05 | 176 | 53 | 4 | c29d09ecf0eb17f767d78af4b7f2e7725c967ff8 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-A_(Fibroblast_progenitors)|343B / Donor, Lineage, Cell class and subclass (all cells) | 5.71e-05 | 176 | 53 | 4 | f33ab41d121b59d871ad7d48ca021524a027d2ef | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells|metastatic_Lymph_Node / Location, Cell class and cell subclass | 5.83e-05 | 177 | 53 | 4 | 71bf5d4bc67bda37a0499e5ec01af7dd5254041d | |
| ToppCell | droplet-Marrow-BM-1m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.83e-05 | 177 | 53 | 4 | 26bad614560609d318bfc9c235a698bca4e1c22c | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-Glia_3_(BCAN+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.83e-05 | 177 | 53 | 4 | d05497d2c80a66ec6a4e1733fea3a5534877a6a7 | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-05 | 178 | 53 | 4 | 27497dbfcf9bb4dd0bf7caa0bd78c7e85f5c18ee | |
| ToppCell | facs-Lung-EPCAM-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.96e-05 | 178 | 53 | 4 | d348a9550db940d204706529759dc51e30506b5f | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-interstitial_macrophage|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.96e-05 | 178 | 53 | 4 | c85de851b39cb8ef7ea1866ab64c6a387788273a | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.09e-05 | 179 | 53 | 4 | e6ae070b4c52ba08167c7d64ea4cfbac0454c1bf | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_3-GABA_SST-Inh_L5-6_SST_TH|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.09e-05 | 179 | 53 | 4 | 797d165718dd1d819e65add3a7859f87b32238a5 | |
| Computational | Oxidoreductases. | 5.18e-07 | 22 | 33 | 4 | MODULE_373 | |
| Computational | Metal / Ca ion binding. | 2.70e-06 | 133 | 33 | 6 | MODULE_324 | |
| Computational | Genes in the cancer module 514. | 3.12e-06 | 10 | 33 | 3 | MODULE_514 | |
| Computational | Neighborhood of IGFBP1 | 6.89e-04 | 57 | 33 | 3 | CAR_IGFBP1 | |
| Drug | 2-NA | 3.27e-09 | 9 | 53 | 4 | CID000074128 | |
| Drug | (3R,7R)-17-(6-hydroxy-1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol | 3.27e-09 | 9 | 53 | 4 | CID000440672 | |
| Drug | 4-Iodopyrazole | 1.19e-08 | 3 | 53 | 3 | DB02721 | |
| Drug | AC1L1J0I | 1.28e-08 | 12 | 53 | 4 | CID000030201 | |
| Drug | hexa-2,4-dien-1-ol | 1.28e-08 | 12 | 53 | 4 | CID000008104 | |
| Drug | 2-naphthaldehyde | 1.84e-08 | 13 | 53 | 4 | CID000006201 | |
| Drug | naphthalenemethanol | 2.57e-08 | 14 | 53 | 4 | CID000020908 | |
| Drug | 6-[(3R,7R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanal | 3.50e-08 | 15 | 53 | 4 | CID000440673 | |
| Drug | naphthaldehyde | 4.66e-08 | 16 | 53 | 4 | CID000006195 | |
| Drug | Fomepizole | 4.76e-08 | 4 | 53 | 3 | DB01213 | |
| Drug | Ethylene Glycol | 1.52e-07 | 21 | 53 | 4 | ctd:D019855 | |
| Drug | Ethanol | 4.14e-07 | 7 | 53 | 3 | DB00898 | |
| Drug | fomepizole | 4.41e-07 | 27 | 53 | 4 | ctd:C010238 | |
| Drug | dhmal | 5.95e-07 | 29 | 53 | 4 | CID000151725 | |
| Drug | N-heptylformamide | 6.62e-07 | 8 | 53 | 3 | CID000347402 | |
| Drug | AC1L1AOQ | 6.86e-07 | 30 | 53 | 4 | CID000001082 | |
| Drug | willardine | 8.96e-07 | 32 | 53 | 4 | CID000005123 | |
| Drug | walrycin A | 8.96e-07 | 32 | 53 | 4 | ctd:C574123 | |
| Drug | Cimetidine | 9.18e-07 | 76 | 53 | 5 | ctd:D002927 | |
| Drug | DOPEG | 1.46e-06 | 36 | 53 | 4 | CID000091528 | |
| Drug | 2-Propanol | 2.03e-06 | 39 | 53 | 4 | ctd:D019840 | |
| Drug | Nicotinamide-Adenine-Dinucleotide | 2.25e-06 | 40 | 53 | 4 | DB01907 | |
| Drug | 3-methylbutanal | 3.35e-06 | 13 | 53 | 3 | CID000011552 | |
| Drug | AG-013608 [351320-38-2]; Up 200; 10uM; MCF7; HT_HG-U133A | 6.18e-06 | 196 | 53 | 6 | 6435_UP | |
| Drug | Finasteride [98319-26-7]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 6.36e-06 | 197 | 53 | 6 | 4766_UP | |
| Drug | phenoxyethanol | 6.53e-06 | 16 | 53 | 3 | CID000031236 | |
| Drug | C x F | 1.12e-05 | 19 | 53 | 3 | CID000013017 | |
| Drug | Peony | 1.32e-05 | 20 | 53 | 3 | CID005483934 | |
| Drug | 4-iodopyrazole | 1.54e-05 | 21 | 53 | 3 | CID000077022 | |
| Drug | 2-butoxyethanol | 2.33e-05 | 24 | 53 | 3 | CID000008133 | |
| Drug | 2,2,2-trichloroethanol | 2.53e-05 | 73 | 53 | 4 | CID000008259 | |
| Drug | 4-methylpiperazine-2,6-dione | 2.98e-05 | 26 | 53 | 3 | CID000124723 | |
| Drug | benzyl alcohol | 4.20e-05 | 83 | 53 | 4 | CID000000244 | |
| Drug | 4-methylpyrazole | 4.40e-05 | 84 | 53 | 4 | CID000003406 | |
| Drug | Methanol | 5.11e-05 | 31 | 53 | 3 | ctd:D000432 | |
| Drug | 3-hydroxyundecanoate | 5.29e-05 | 5 | 53 | 2 | CID003083221 | |
| Drug | N-1-methylheptylformamide | 5.29e-05 | 5 | 53 | 2 | CID005478865 | |
| Drug | 3-hydroxynonanoate | 5.29e-05 | 5 | 53 | 2 | CID000036599 | |
| Drug | Flunisolide [3385-03-3]; Down 200; 9.2uM; PC3; HT_HG-U133A | 8.78e-05 | 194 | 53 | 5 | 3747_DN | |
| Drug | Amikacin hydrate [37517-28-5]; Up 200; 6.6uM; PC3; HT_HG-U133A | 9.22e-05 | 196 | 53 | 5 | 6715_UP | |
| Drug | tamoxifen citrate; Up 200; 1uM; MCF7; HG-U133A | 9.90e-05 | 199 | 53 | 5 | 143_UP | |
| Drug | 3-butylthiolane 1-oxide | 1.11e-04 | 7 | 53 | 2 | CID003363251 | |
| Drug | 1-MCP | 1.19e-04 | 41 | 53 | 3 | CID000151080 | |
| Drug | Retinaldehyde | 1.28e-04 | 42 | 53 | 3 | ctd:D012172 | |
| Drug | 5-butyl-2-phenoxyphenol | 1.48e-04 | 8 | 53 | 2 | CID005274975 | |
| Drug | 3-keto-LCA | 1.48e-04 | 8 | 53 | 2 | CID000159623 | |
| Drug | AC1NBLOP | 1.48e-04 | 8 | 53 | 2 | CID004469995 | |
| Drug | 12-oxododecanoic acid | 1.89e-04 | 9 | 53 | 2 | CID000077563 | |
| Drug | Nile red | 2.16e-04 | 50 | 53 | 3 | CID000065182 | |
| Drug | EGEE | 2.29e-04 | 51 | 53 | 3 | CID000008076 | |
| Drug | chloral hydrate | 2.32e-04 | 129 | 53 | 4 | CID000002707 | |
| Drug | verbenone | 2.36e-04 | 10 | 53 | 2 | CID000029025 | |
| Drug | AC1L1G72 | 2.89e-04 | 11 | 53 | 2 | CID000003553 | |
| Drug | hex-2-en-1-ol | 2.89e-04 | 11 | 53 | 2 | CID000013577 | |
| Drug | glyceraldehyde | 3.17e-04 | 140 | 53 | 4 | CID000000751 | |
| Drug | cysteinylglycine | 3.19e-04 | 57 | 53 | 3 | CID000065270 | |
| Drug | 1H-pyrazol | 3.26e-04 | 141 | 53 | 4 | CID000001048 | |
| Drug | AC1L590V | 3.46e-04 | 12 | 53 | 2 | CID000172417 | |
| Drug | heptadecane | 3.46e-04 | 12 | 53 | 2 | CID000012398 | |
| Drug | CC270 | 3.53e-04 | 59 | 53 | 3 | CID006918852 | |
| Drug | NADH | 3.53e-04 | 144 | 53 | 4 | DB00157 | |
| Drug | UDP-alpha-d-xylopyranose | 3.71e-04 | 60 | 53 | 3 | CID000001165 | |
| Disease | alcohol dependence measurement | 3.35e-08 | 55 | 49 | 5 | EFO_0007835 | |
| Disease | Malignant neoplasm of larynx | 2.70e-06 | 2 | 49 | 2 | C0007107 | |
| Disease | Malignant neoplasm of pharynx | 2.70e-06 | 2 | 49 | 2 | C0153405 | |
| Disease | Laryngeal neoplasm | 2.70e-06 | 2 | 49 | 2 | C0023055 | |
| Disease | Pharyngeal Neoplasms | 2.70e-06 | 2 | 49 | 2 | C0031347 | |
| Disease | Alcoholic Intoxication, Chronic | 5.35e-06 | 268 | 49 | 6 | C0001973 | |
| Disease | alcohol use disorder measurement, alcohol dependence | 8.50e-06 | 24 | 49 | 3 | EFO_0009458, MONDO_0007079 | |
| Disease | alcohol dependence | 1.33e-05 | 183 | 49 | 5 | MONDO_0007079 | |
| Disease | Alcohol dependence | 2.69e-05 | 5 | 49 | 2 | cv:C0001973 | |
| Disease | ALCOHOL DEPENDENCE | 2.69e-05 | 5 | 49 | 2 | 103780 | |
| Disease | alcohol use disorder measurement, longitudinal alcohol consumption measurement | 3.21e-05 | 37 | 49 | 3 | EFO_0007645, EFO_0009458 | |
| Disease | Alcohol Use Disorder | 5.43e-05 | 44 | 49 | 3 | C0001956 | |
| Disease | upper aerodigestive tract neoplasm | 5.47e-05 | 246 | 49 | 5 | EFO_0004284 | |
| Disease | bitter alcoholic beverage consumption measurement | 7.14e-05 | 133 | 49 | 4 | EFO_0010092 | |
| Disease | Colorectal Neoplasms | 9.57e-05 | 277 | 49 | 5 | C0009404 | |
| Disease | Mouth Neoplasms | 1.01e-04 | 54 | 49 | 3 | C0026640 | |
| Disease | Malignant neoplasm of mouth | 1.01e-04 | 54 | 49 | 3 | C0153381 | |
| Disease | Alcohol abuse | 1.91e-04 | 67 | 49 | 3 | C0085762 | |
| Disease | Non-alcoholic Fatty Liver Disease | 2.18e-04 | 70 | 49 | 3 | C0400966 | |
| Disease | Nonalcoholic Steatohepatitis | 2.18e-04 | 70 | 49 | 3 | C3241937 | |
| Disease | total brain volume change measurement | 2.43e-04 | 14 | 49 | 2 | EFO_0021504 | |
| Disease | Esophageal Neoplasms | 3.00e-04 | 78 | 49 | 3 | C0014859 | |
| Disease | unipolar depression, alcohol dependence | 3.00e-04 | 78 | 49 | 3 | EFO_0003761, MONDO_0007079 | |
| Disease | Malignant neoplasm of esophagus | 3.00e-04 | 78 | 49 | 3 | C0546837 | |
| Disease | alcohol use disorder (is_implicated_in) | 3.19e-04 | 16 | 49 | 2 | DOID:1574 (is_implicated_in) | |
| Disease | Schizoaffective disorder-bipolar type | 3.19e-04 | 16 | 49 | 2 | EFO_0009965 | |
| Disease | high altitude adaptation | 3.62e-04 | 17 | 49 | 2 | EFO_0009105 | |
| Disease | alcohol use disorder measurement | 4.41e-04 | 214 | 49 | 4 | EFO_0009458 | |
| Disease | facial asymmetry measurement | 4.54e-04 | 19 | 49 | 2 | EFO_0009751 | |
| Disease | sex interaction measurement, cerebral amyloid angiopathy | 5.56e-04 | 21 | 49 | 2 | EFO_0006790, EFO_0008343 | |
| Disease | parental emotion expression measurmement, conduct disorder | 7.91e-04 | 25 | 49 | 2 | EFO_0004216, EFO_0008342 | |
| Disease | medial orbital frontal cortex volume measurement | 7.91e-04 | 25 | 49 | 2 | EFO_0010315 | |
| Disease | lower face morphology measurement | 7.98e-04 | 109 | 49 | 3 | EFO_0010948 | |
| Disease | myeloperoxidase measurement | 8.56e-04 | 26 | 49 | 2 | EFO_0005243 | |
| Disease | esophageal carcinoma | 1.14e-03 | 30 | 49 | 2 | EFO_0002916 | |
| Disease | Alcoholic Intoxication | 1.30e-03 | 32 | 49 | 2 | C0001969 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VCLIGCGFSTGYGAA | 181 | P40394 | |
| GGSGEACVACPSGSY | 271 | P21709 | |
| PEGTGACYGSGICSC | 456 | Q5FYA8 | |
| CLIGCGFSTGYGSAV | 171 | P07327 | |
| CLIGCGFSTGYGSAV | 171 | P00325 | |
| CLIGCGFSTGYGSAV | 171 | P00326 | |
| EGSVTGSCYCGKRIS | 31 | Q9H2A7 | |
| VCKSIGSSGTSPPYC | 151 | Q9H6U6 | |
| SAGGSKCVSNTPGYC | 21 | Q7Z7B7 | |
| YGPTFTTGDVIGCCV | 271 | Q96S59 | |
| SGGISITSSCYPGDG | 1511 | O95153 | |
| HVTGTCYCSPGFKGI | 806 | A6BM72 | |
| GGCTGSSSACYALAT | 706 | Q96RG2 | |
| FPCGAAGTSGATACY | 361 | Q7Z4F1 | |
| NGSGPCTYTISGSRE | 501 | Q86VH4 | |
| FFPCSATCGGGYQLT | 306 | Q8N6G6 | |
| GHGTCTSPGCSFTYV | 311 | Q12766 | |
| VGGSAICSCFPGYAI | 696 | P98095 | |
| VRGPCSTYGCGSDSV | 246 | Q9NRQ2 | |
| DGFTCDCTMTSYGGP | 1116 | Q9P2S2 | |
| TCDCSTTGYGGKLCS | 221 | Q9Y4C0 | |
| TSTVYCHGGGSCKIT | 1701 | Q9HD67 | |
| YPSFSISGTCGSSCC | 11 | Q9BYS1 | |
| CGYAVGGSGVSATPA | 331 | Q86UT6 | |
| DCTVRGLGPSYCSFG | 111 | P01225 | |
| GGYCGKCTPSSGTGL | 1916 | Q9P2N4 | |
| DSQALCSCYGGGLGT | 56 | Q9UIH9 | |
| GTQCGECSTGFYGNP | 946 | A4D0S4 | |
| GYGSRSCYSVGCGSS | 111 | Q8IUC0 | |
| SCYSVGCGSSGFRSL | 116 | Q8IUC0 | |
| PCKTTYSGSLGFGSS | 91 | Q52LG2 | |
| GYGSRSCYSVGCGSS | 111 | Q52LG2 | |
| SCYSVGCGSSGVRSL | 116 | Q52LG2 | |
| GFSCLCPSGYTGSLC | 466 | P82279 | |
| MCSSSGYVVQGCGPS | 16 | Q6ZPB5 | |
| GGKSSCPVCGISYSF | 51 | Q9BYJ4 | |
| CVGGTAGCDSYTPKV | 66 | Q96BY9 | |
| CTSKYSSPFPCTGGE | 181 | Q9HB63 | |
| CDVCTSGYYGKVTGS | 1431 | P25391 | |
| GFSTDSGQCPEGYTC | 316 | Q15858 | |
| GNPSYTCSCLSGFTG | 291 | Q8TER0 | |
| TNALGSYSCGCIAGF | 286 | Q14246 | |
| CPSGSSGTTVIYTCE | 436 | Q8IZF2 | |
| STKTSYCLAAGGGVF | 1481 | O75443 | |
| GTKFTCGFDGCGSTY | 951 | Q13129 | |
| GLSGCSPRDSGCYES | 716 | O94885 | |
| SNGTASCICKAGYEG | 846 | Q8WWQ8 | |
| CSTTCFNGGTCFYPG | 246 | Q9Y5W5 | |
| YTCGVCGKGFSYTSG | 796 | Q9UJW7 | |
| KEGGCVPSSTSSSGY | 116 | Q6ZNC4 | |
| GCPAEGCGKSFTTVY | 331 | P98168 | |
| CSTVGGVGYGDSKDC | 21 | Q9NRM2 | |
| TTECSTTCGKGSQYP | 626 | Q6ZMP0 | |
| PSNCTVYCGGVTSGL | 211 | P31483 | |
| TGEKSYVCSVCGRGF | 231 | Q9Y3M9 | |
| TGERPYTCGVCGKSF | 171 | Q5EBL2 | |
| CLTCGTFIGDGDTYT | 111 | P53667 |